Glinate M 2mg/500mg Tablet SR
By Glinate M
Rx
10 Tablet PR in a Strip

Composition
Glimepiride(2mg) + Metformin(500mg)

Manufacturer - Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Limited, B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026.

Expires on or after
October, 2025

liver
Glinate M 2mg/500mg Tablet SR should be used carefully by individuals with liver disease. Adjusting the dose of Glinate M 2mg/500mg Tablet SR may be necessary, so it's vital to seek advice from your healthcare provider. Typically, Glinate M 2mg/500mg Tablet SR is initiated at a low dosage for those with mild to moderate liver issues. However, it is advised to avoid using this medication in individuals with severe liver disease. If you have liver concerns, consult your doctor before using Glinate M 2mg/500mg Tablet SR.

kidney
Caution should be exercised with Glinate M 2mg/500mg Tablet SR in patients with kidney disease. Dose adjustment may be necessary, and it is advised to consult your doctor. Avoid use in severe kidney disease. Regular kidney function tests are recommended during treatment.

alcohol
It is not safe to drink alcohol while taking Glinate M 2mg/500mg Tablet SR.

driving
When taking Glinate M 2mg/500mg Tablet SR, avoid driving if you experience low or high blood sugar symptoms that can affect your ability to drive safely.

pregnancy
Glinate M 2mg/500mg Tablet SR may not be safe during pregnancy. Animal studies indicate potential harm to the developing baby. Consult your doctor, as they will assess the risks and benefits before prescribing this medication to you.

breastfeeding
Glinate M 2mg/500mg Tablet SR should be avoided during breastfeeding due to potential harm to the baby.
Habit Forming | No |
Chemical Class | Biguanide |
Therapeutic Class | ANTI DIABETIC |
Action Class | Sulfonylureas (Insulin Secretogogues) |
₹95
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024